• Home
  • EMCrit-RACC
  • PulmCrit
  • IBCC
  • EMNerd
  • Tox & Hound
  • About
    • About EMCrit
    • About PulmCrit
    • EMCrit FAQ
    • Subscription Options
  • Contact Us

PulmCrit (EMCrit)

Online Medical Education on Emergency Department (ED) Critical Care, Trauma, and Resuscitation

  • About PulmCrit
  • Genius General Hospital
  • PulmCrit TOC
  • IBCC TOC
  • IBCC Podcast
You are here: Home / Archives for PULMCrit

IBCC chapter – Disseminated Intravascular Coagulation (DIC)

January 18, 2021 by Josh Farkas Leave a Comment

Disseminated Intravascular Coagulation (DIC) is like the ARDS of the hematological system.  It’s not really one disorder, but rather a collection of different disorders with some shared features.  The diagnosis and optimal treatment remain elusive. The IBCC chapter is located 👉 here. The podcast & comments are below. Follow us on iTunes  

PulmCrit- RCTs don’t justify using convalescent plasma or antibody cocktails

January 14, 2021 by Josh Farkas 1 Comment

Passive immunity refers to the infusion of antibodies (either polyclonal antibodies in the form of convalescent plasma, or engineered monoclonal antibodies).  The goal is to neutralize viral particles, reduce viral replication, and thereby improve clinical outcomes.  This is a promising theory, but it requires evidentiary support in the form of randomized controlled trials.  So far, […]

PulmCrit – Six RCTs to answer one question: what is the role of tocilizumab in COVID-19?

January 12, 2021 by Josh Farkas 3 Comments

The REMAP-CAP trial recently detected mortality benefit from tocilizumab in patients with COVID-19.  However, several other RCTs have failed to find substantial benefit from tocilizumab.  This begs the question:  Has REMAP-CAP discovered a uniquely beneficial way to use tocilizumab, or is this simply a statistical outlier?   evidence roundup:  RCTs on tocilizumab Let’s review the trials.  […]

IBCC – Purpura Fulminans

January 4, 2021 by Josh Farkas 4 Comments

Purpura fulminans is a rare form of disseminated intravascular coagulation which requires specific management.  Most commonly it is seen as a complication of septic shock with multi-organ failure.  Unfortunately, purpura fulminans is often treated simply with a generic approach for septic shock. The IBCC chapter is located 👉 here. The podcast & comments are below. […]

PulmCrit – Baricitinib for COVID-19: The rise of the jakinibs

December 31, 2020 by Josh Farkas 4 Comments

Background:  JAK-inhibitors (jakinibs) in the greater context Much of the harm from infections is mediated by hyperactive inflammatory reactions.  To date, most research has focused on two classes of medications to treat this: Corticosteroids have the advantage of being cheap, widely available, and often effective.  The disadvantage is that corticosteroids modulate innumerable molecular pathways, thereby […]

  • 1
  • 2
  • 3
  • …
  • 80
  • Next Page »

Follow EMCrit Everywhere

Click for More Subscribe Options


Other Stuff

  • Have a great idea for the next podcast? Share it here!
  • Tough Questions. Maybe you have an answer!
  • When you're done listening to the podcast,
    check out these great sites.

Who We Are

We are the EMCrit Project, a team of independent medical bloggers and podcasters joined together by our common love of cutting-edge care, iconoclastic ramblings, and FOAM.

Like Us on Facebook

Like Us on Facebook

Subscribe by Email

EMCrit is a trademark of Metasin LLC. Copyright 2009-. This site represents our opinions only. See our full disclaimer, our privacy policy, commenting policy and here for credits and attribution.